113 related articles for article (PubMed ID: 31066594)
1. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia.
Novick D; Leonardi F; Lee Kay Pen D; Montoya-Restrepo ME; Avendaño C; Siddi S; Moneta MV; Haro JM; Velasquez JC
J Med Econ; 2019 Sep; 22(9):891-900. PubMed ID: 31066594
[No Abstract] [Full Text] [Related]
2. Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina.
Novick D; Mendez G; Carballido M; Rizzo M; O'Connor JM; Castillo J; Lee Kay Pen D; Siddi S; Rodante D; Moneta MV; Haro JM
Medwave; 2019 Sep; 19(8):e7692. PubMed ID: 31596840
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil.
de Alencar Camara Vieira FM; de Souza Victorino APO; de Iracema Gomes Cubero D; Beato CAM; Minowa E; Julian GS; Novick D
J Gastrointest Cancer; 2019 Dec; 50(4):780-793. PubMed ID: 30078125
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
Choi IS; Choi M; Lee JH; Kim JH; Suh KJ; Lee JY; Kang B; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
PLoS One; 2018; 13(6):e0198544. PubMed ID: 29879177
[TBL] [Abstract][Full Text] [Related]
5. Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
Brown J; Liepa AM; Bapat B; Madhwani S; Lorenzen S; García-Foncillas J; Candrilli SD; Kaye JA
Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13213. PubMed ID: 31883156
[TBL] [Abstract][Full Text] [Related]
6. 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane.
Erdem GU; Bozkaya Y; Ozdemir NY; Demirci NS; Yazici O; Zengin N
Bosn J Basic Med Sci; 2018 May; 18(2):170-177. PubMed ID: 28941466
[TBL] [Abstract][Full Text] [Related]
7. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer.
Kucukzeybek Y; Dirican A; Erten C; Somali I; Can A; Demir L; Bayoglu IV; Akyol M; Medeni M; Tarhan MO
Asian Pac J Cancer Prev; 2012; 13(6):2771-4. PubMed ID: 22938457
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.
Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH
Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
Nishina T; Boku N; Gotoh M; Shimada Y; Hamamoto Y; Yasui H; Yamaguchi K; Kawai H; Nakayama N; Amagai K; Mizusawa J; Nakamura K; Shirao K; Ohtsu A;
Gastric Cancer; 2016 Jul; 19(3):902-10. PubMed ID: 26386560
[TBL] [Abstract][Full Text] [Related]
10. Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer.
Bilici A; Selcukbiricik F; Demir N; Oven Ustaalioglu BB; Dikilitas M; Yildiz O
Asian Pac J Cancer Prev; 2014; 15(20):8661-6. PubMed ID: 25374186
[TBL] [Abstract][Full Text] [Related]
11. A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
Choi IS; Kim JH; Lee JH; Suh KJ; Lee JY; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
PLoS One; 2018; 13(10):e0205853. PubMed ID: 30346970
[TBL] [Abstract][Full Text] [Related]
12. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.
Carter GC; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum HG; Kim JS; Bang YJ
Cancer Res Treat; 2017 Jul; 49(3):578-587. PubMed ID: 27618820
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
Weissinger F; Reymond M; Dumke K; Krüger M
Onkologie; 2011; 34(10):548-51. PubMed ID: 21985855
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns in patients with advanced gastric cancer in Taiwan.
Cuyun Carter G; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum H; Chen JS
Asia Pac J Clin Oncol; 2017 Jun; 13(3):185-194. PubMed ID: 27108762
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
17. Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes.
Park SH; Choi EY; Bang SM; Cho EK; Lee JH; Shin DB; Ki Lee W; Chung M
Anticancer Drugs; 2005 Jul; 16(6):621-5. PubMed ID: 15930889
[TBL] [Abstract][Full Text] [Related]
18. Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
Polyzos A; Felekouras E; Karatzas T; Griniatsos J; Dimitroulis D; Polyzos K; Kontzoglou K; Mantas D; Karavokyros J; Nikiteas N; Tsavaris N; Syrigos K; Vafiadis I
Anticancer Res; 2012 Sep; 32(9):4151-6. PubMed ID: 22993377
[TBL] [Abstract][Full Text] [Related]
19. [Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
Jiang ZC; Chi Y
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):631-635. PubMed ID: 30139036
[No Abstract] [Full Text] [Related]
20. Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer.
Kim ST; Kang WK; Kang JH; Park KW; Lee J; Lee SH; Park JO; Kim K; Kim WS; Jung CW; Park YS; Im YH; Park K
Br J Cancer; 2005 May; 92(10):1850-4. PubMed ID: 15870718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]